The Central Nervous Systems Market 2010 Report

NeuroInsights, May 2010

Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global Neurological Disease and Psychiatric Illness Markets

Now in its sixth year, The CNS Market 2010 Report is an expanded and updated 500 page report of brain and nervous system markets and treatments. It is the only publication to provide a comprehensive pipeline and market analysis to help investors, companies and entrepreneurs easily identify opportunities, understand the competitive landscape, determine risks and understand the dynamics of rapidly changing CNS markets.

The report includes detailed information on products in development globally for over 18 indications at 800 companies including Alzheimer's, addiction, ALS, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, Huntington's, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, and stroke.

Report Highlights

The CNS Market 2010 Report provides a unified market-based framework to help executives, investors, and governments easily identify opportunities, understand the competitive landscape and visualize the dynamics of these rapidly growing markets.

- More than 500 profiles of public and private neurotech companies including drugs, devices and diagnostics

- 12 most active neurotech venture capital firms profiled with investments by market segment and U.S. neurotech venture capital trends (1999-Q12010)

- Neurotech IPOs (2004-Q12010), M&A (2004-Q12010), Partnering and Licensing deals (2005-Q12010) and public neurotech stock performance

- Pipelines and market analysis for 18 brain and nervous system illnesses including: addiction, Alzheimer's disease, anxiety, attention disorders, depression, epilepsy, hearing loss, insomnia, mild cognitive impairment, migraine, multiple sclerosis, obesity, pain, Parkinson's disease, retinal disorders, schizophrenia and stroke

- Analysis of biological basis, current treatment options, and emerging therapeutic strategies

- Analysis of compounds, cell therapies and devices in clinical trials (and abandoned) by company, mechanism of action and stage of development for each indication

- Global and US market size, worldwide revenues for each indication

- Extensive discussion of specific technological, demographic, regulatory and intellectual property

1: Executive Summary

The Brain Industry Revealed
Neuropharmaceuticals
Neurodevices
Neurodiagnostics
Investment Risks and Opportunities
Translating Neuroscience into Neurotech
The Neurotech Market Opportunity
NASDAQ NeuroInsights Neurotech Index
Neurotechnology and Society
Key Industry Facts and Findings
Market Overview
Industry Overview
Venture Financing
Public Market Activity
Global Growth Drivers
Other Findings
A Brief History of the Science Behind Neurotechnology

2: Trends and Drivers

Converging Technology Drivers
Stem Cells and Neuroregeneration
Neuroimaging, Diagnostics and Disease Treatment
Crossing the Blood Brain Barrier
Demographic Drivers
More People Living Longer
Social Drivers
The Lifestyle Improvement Market
Medical Tourism
Economic Drivers
Global Economic Burden of Brain-Related Illness
Rising Health Care Costs
Research Funding
US Government Research Funding
Stem Cell Funding
International Government Research Funding
Foundations Focus on the Brain
Regulatory Trends
World Regulatory Agencies
Global Clinical Trials
Intellectual Property Trends
Global Intellectual Property Protection
Patent Expirations
Patent Activity in the United States

3: Neuropharmaceutical Sector

Neuropharmaceutical Sector Overview
Trends in Neuropharmaceuticals
Spotlight on Big Pharma
Neuropharmaceutical Partnering and Licensing
Neurology Markets and Pipelines
Alzheimer's Disease (AD)
AAMI and MCI
Epilepsy and Seizure Disorders
Migraine
Multiple Sclerosis
Parkinson's Disease
Sleep Disorders
Restless Legs Syndrome
Stroke
Psychiatry Markets and Pipelines
Addiction
Anxiety Disorders
Attention Disorders
Depressive Disorders
Bipolar Disorder
Obesity
Schizophrenia
Cognitive Impairment Associated with Schizophrenia
Sensory Markets and Pipelines
Pain
Retinal Disorders

4: Stem Cells and Neuroregeneration

Defining Stem Cell Markets and Players
Therapeutics
Drug Discovery Tools
Stem Cell Banking
Stem Cell Approaches
Background
The Science of Transplantion
Controlling Immune Rejection and Infection
Sources and Harvesting of Stem Cells
Embronic Stem Cells
Fetal Stem Cells
Adult Stem Cells
Stimulation of Endogenous Stem Cells
Stem Cells Scientific Hurdles
Markets and Treatments in Development
Alzheimer's Disease
Amyotrophic Lateral Sclerosis (ALS)
Hearing Loss
Huntington's Disease (HD)
Multiple Sclerosis (MS)
Parkinson's Disease
Retinal Disorders
Spinal Cord Injury (SCI)
Stroke
Other CNS Diseases

5: Neurodevice Sector

Neurodevice Sector Overview
Neurodevice Markets
FDA Classification and Approval Process
Neurodevice Sector Trends
Neuroprosthetic Devices
Cochlear Implants
Retinal Implants
Motor Prostheses and Brain Computer Interfaces
Neuromodulation Devices
Neuromodulation Device Clinial Trials and Recent Approvals
Deep Brain Stimulation
Essential Tremor
Parkinson's Disease
Primary Dystonia
Severe Obsessive Compulsive Disorder
Treatment-Resistant Depression
Epilepsy
Traumatic Brain Injury and Stroke
Transcranial Magnetic Stimulation (TMS)
Treatment Resistant Depression
Migraine
Spinal Cord Stimulation (SCS)
Chronic and Neuropathic Pain
Spinal Cord Injury
Vagus Nerve Stimulation (VNS)
Epilepsy
Treatment-Resistant Depression
Obesity
Peripheral Stimulation
Balance
Drug Delivery
Fecal Incontinence
Foot Drop
Hypertension
Migraine
Neuropathic Pain
Restless Legs Syndrome
Sleep Apnea
Stroke
Urinary Conditions
Gastric Modulation and Obesity
Neurosurgical devices
Radiosurgical Devices
Neurosurgical Navigation and Equipment
Image Guided Navigation (IGN)
Intraoperative Magnetic Resonance Imaging (iMRI)
Automated Surgical Systems
Brain Monitoring
Temperature Control Systems
Neurovascular Intervention
Ischemic Stroke
Catheters, Stents and Perfusion devices
Retrieval and Protection devices
Ultrasound Thrombolysis
Hemorrhagic Stroke
Coils
Liquid Embolics
Stents
Neurosoftware
Attention Deficit Disorder
Cognition and Aging
Emotional Wellbeing
Learning Disabilities and Autism
Pain

6: Neurodiagnostics Sector

Neurodiagnostic Sector Overview
FDA Approval and Insurance Reimbursement of Diagnostics
Neuroimaging Technologies
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Nuclear Medicine Imaging (PET, SPECT)
Electro-encephalography (EEG)
Magneto-encephalography (MEG)
In Vitro Diagnostics
In Vitro Diagnostics Regulatory Landscape
Emerging Diagnostics for Alzheimer's Disease
Genetic Testing and Pharmacogenomics
Protein Biomarker Assays
Pattern Recognition in Diagnostics
Emerging Diagnostics for Psychiatry
Neuroinformatics
Diagnostic Software

7: Private Neurotechnology Investment

Private Investment in Neurotechnology
Venture Capital Investment Trends
Neurotech Venture Capital Investment
Investing in Neuropharmaceuticals
Investing in Stem Cells and Neuroregeneration
Investing in Neurodevices
Investing in Neurodiagnostics
Private Company Financings, 2010
Top financings 2004-2009
Leading Neurotech Venture Capital Firms

8: Public Neurotechnology Investment

Investing in Public Neurotech Companies
Neurotech Stock Universe
Neurotech Initial Public Offerings
Neurotech M&A Activity
NASDAQ NeuroInsights Neurotech Index

9: Neurotechnology Research Centers

Leading Neurotechnology Research Centers
University of California, San Francisco (UCSF)
University of California, Los Angeles (UCLA)
University of California, San Diego (UCSD)
Harvard
Stanford University
Massachusetts Institute of Technology (MIT)
Columbia University
Washington University, St. Louis
University College London (UCL)
Karolinska Institutet, Stockholm
RIKEN Brain Science Institute, Japan
Places to Watch
National Brain Research Centre (NBRC), India
Neurosciences Victoria, Australia (NSV)
Shanghai Institute of Brain Functional Genomics (SBG), China

10: Leading Neurotechnology Regions

The Global Neurotech Economy
Nexus Ranking and Methodology
Established Neurotech Nexus'
Emerging Neurotech Nexus'
Nascent Neurotech Nexus'
Conclusions and Policy Recommendations

11: Company Profiles

Neuropharmaceutical Companies: Private
Neuropharmaceutical Companies: Public
Neurodevice Companies: Private
Neurodevice Companies: Public
Neurodiagnostic Companies: Private
Neurodiagnostic Companies: Public

12: Index

The CNS Market 2010 Report: Exhibits, Tables, and Charts

1-1: Number of Individuals Afflicted by Indication, US and Worldwide, Top 15 Indications
1-2: Global Pharmaceutical Sales by Indication, 2009
1-3: Neurotechnology Industry Taxonomy
1-4: Proportion of Patient Population Segmented by Neurotech Market Opportunity
1-5: NASDAQ NeuroInsights Neurotech Index Performance vs. S&P500, NASQAQ Composite, and NASDAQ Biotechnology Index

2-1: Projected Percentage Increase in Global Populations aged 65 and over, 1994-2020
2-2: Neuropharmaceutical Patent Expirations and Generic Competition, 2003-2012
2-3: Neurotechnology Patent Approvals, US, 1985-2007
2-4: Neuropharmaceutical Patent Approvals, US, 1985-2007
2-5: Neurodevice Patent Approvals, US, 1985-2007
2-6: Neurodiagnostic Patent Approvals, US, 1985-2007
2-7: Selected US Foundations with a Significant focus on Brain Research and Education
2-8: Most Generous Philanthropists for Medical and Brain Research
2-9: Global Stem Cell Policy Map

3-1: Neuropharmaceutical Revenues by Indication (2009)
3-2: FDA Pharmaceutical Approval Process
3-3: Big Pharma neuropharmaceutical revenues
3-4: Neuropharmaceutical Partnering and Licensing Deals 2004-Q1 2010
3-5: Clinical Trials for Alzheimer's disease (company, compound, phase, mechanism)
3-6: Worldwide revenues of leading anti-epileptics (2004-2009)
3-7: Clinical Trials for Epilepsy (company, compound, phase, mechanism)
3-8: Clinical Trials for Migraine (company, compound, phase, mechanism)
3-9: Clinical Trials for Multiple sclerosis (company, compound, phase, mechanism)
3-10: Clinical Trials for Mild Cognitive impairment (company, compound, phase, mechanism)
3-11: Clinical Trials for Parkinson's disease (company, compound, phase, mechanism)
3-12: Clinical Trials for sleep disorders (company, compound, phase, mechanism)
3-13: Clinical Trials for stroke Treatment (company, compound, phase, mechanism)
3-14: Number of People with Addiction and Impulse Control Disorders (WW and US)
3-15: Clinical Trials for addition and substance abuse (company, compound, phase, mechanism)
3-16: Clinical Trials for anxiety disorders (company, compound, phase, mechanism)
3-17: Clinical Trials for ADHD (company, compound, phase, mechanism)
3-18: Clinical Trials for Depressive disorders (company, compound, phase, mechanism)
3-19: Clinical Trials for Obesity Treatment (company, compound, phase, mechanism)
3-20: Clinical Trials for Schizophrenia and psychosis (company, compound, phase, mechanism)
3-21: Clinical Trials for Retinal disorders (company, compound, phase, mechanism)
3-22: Clinical Trials for Pain (company, compound, phase, mechanism)

4-1: FDA Classification and Approval Process for Medical Devices
4-2: Neurodevice Acquisition and Investment Activity: Medtronic, Boston Scientific, J&J
4-3: Neurodevice Markets (Neuroprosthetic, Neuromodulation, Neurosurgical, Neurofeedback)
4-4: Neuromodulation Device Clinical Trials

5-1: Neurodiagnostics Markets and Annual Growth (Neuroimaging, In Vitro Diagnostics, Neuroinformatics)
5-2: FDA Approval and Insurance Reimbursement of Diagnostics
5-3: Neuroimaging Technology (CT, MRI, fMRI, PET, SPECT, EEG, MEG)
5-6: Alzheimer's Disease Neuroimaging Initiative
5-7: Neuroinformatics Data Storage
5-8: Paul Allen Brain Atlas Project and IBM Blue Brain Project

6-1: Total US Venture Capital Investment, 1999-2009
6-2: US Life Science Venture Capital Investment, 1999-2009
6-3: US Neurotechnology Venture Capital Investment, 1999-2009
6-4: Neurotech as Percent of Life Science Venture Investment, 1999-2009
6-5: Top Five Neurotechnology Venture Capital Financings, 2001-2009
6-6: Top 12 Neurotech Venture Capital Firms with Investments

7-1: Neurotechnology Initial Public Offerings US, 2004-Q1 2010
7-2: Selected Neurotech M&A Activity, 2004-Q1 2010
7-3: Neurotech Index Companies 2010
7-4: Neurotech Index Company Fundamentals
7-5: Index Company Performance

8-1 Leading Neurotechnology Research Centers
8-2 Neurotech Research Centers and Affiliated Institutes, Funding, Recent Significant Investments, Reputation, Translation of Discoveries to Industry
8-3: UCSF
8-4: UCLA
8-5: Harvard University
8-6: Stanford University
8-7: MIT
8-8: Columbia University
8-9: Washington University
8-10: University College London
8-11: Karolinska Institute
8-12: RIKEN Brain Science Institute

9-1 NeuroInsights' Leading Neurotech Nexus Ratings
9-2 Conclusions and Policy Recommendations

10-1 Neuropharmaceutical Companies Private Profiles (status, funding, location, investment, descriptions, investors)
10-2 Neuropharmaceutical Companies Public Profiles (status, symbol, HQ, market cap revenues, description)
10-3 Neurodevice Companies Private Profiles (status, funding, location, investment, descriptions, investors)
10-4 Neurodevice Companies Public Profiles (status, symbol, HQ, market cap revenues, description)
10-5 Neurodiagnostic Companies Private Profiles (status, funding, location, investment, descriptions, investors)
10-6 Neurodiagnostic Companies Public Profiles (status, symbol, HQ, market cap revenues, description)

23andMe
7TM Pharmaceuticals

A

Aastrom
AbaStar MDx
Abbey Pharmaceuticals
Abbott
Acadia Pharmaceuticals
Accera
Accuray
AC Immune
Acorda
Actelion
Acucela
Acumen Pharmaceuticals
Acura
Adamas
Addex Pharmaceuticals
Addrenex
Adenios
Adenosine Therapeutics
Adeona
Aderis Pharmaceuticals
Adherex
Adlyfe
Adolor
Advanced Bionics
Advanced Brain Monitoring
Advanced Brain Technologies
Advanced Cell Technology
Advanced Neuromodulation Systems
Aeolus
Affectis
Afferent Pharmaceuticals
AFFiRis
Affymetrix
Afraxis
Agenebio
Alcon
Alexza Pharmaceuticals
AlgoRx Pharmaceuticals
Algos Therapeutics
Alimera
Alinea
Alkermes
Allen Institute for Brain Science
Allergan
Allon Therapeutics
Allozyne
AllTranz Pharmaceuticals
Alnylam
Alpha Omega Engineering
Alpharma
Alseres
Alsius
Alza
Alzhyme
Amarin
Ambrx
Amersham
Amgen
Amicus
Amkor
Amnestix
Amsterdam Molecular
Amylin
Anagen
Anavex
Anesiva
AngioChem
ANM Adaptive
Antisense Therapeutics
Apeiron Biologics
Apnex Medical
Apologic
Applied Cognitive Engineering
Applied NeuroSolutions
Archer Pharmaceuticals
Ardian
Arena Pharmaceuticals
Argolyn
Ariston
ArmaGen
Artielle
ArunA
Aspect Medical
Aspreva
Astellas
AstraZeneca
Astro-Med
AsuraGen
Athena Diagnostics
Athersys
AurimMed Pharma
Auris Medical
Autonomic Technologies
Avacta
AVANIR
Avanir
Avera
Avid Radiopharmaceuticals
Avigen
Avineuro
AxoGen
Axon Neuroscience
Axxonis
Azevan
Azur Pharmaceuticals

B

BaroSense
Baxter
Bayer
Bayhill
Bedford Stem Cell Research Foundation
Beike
BeneChill
BIAL
Bioalvo
BioArctic
BioAxone
BioBehavioral Diagnostics
BioControl Systems
Biocortech
Biogen Idec
BioLineRx
Biomarin
BioMS
Bioness
Bionomics
Biotek
Biotie
Biovail
Biovitrum
Blackrock Microsystems
Boehringer Ingelheim
Boston Scientific
Bracco Diagnostics
BrainBuilder
BrainCells Inc
BrainLAB
Brain Resource
BrainScope
BrainsGate
BrainStorm Cell Therapeutics
Brainsway
Braintact Ltd.
BrainZ
Brane Discovery
Bristol-Myers Squibb
Brittannia Pharmaceuticals
BW Safari

C

Cadence
Cadwell Laboratories
California Stem Cell
Cambria
Cambridge Cognition
Capnia
Capsulution
Cara
Cardium Therapeutics
Carlsson Research
Cary
Catalina Imaging
Catalyst
CCC Medical Devices
Cell Cure Neurosciences
CellMed
Cell Therapeutics
Cellzome
Celtic
CeNeRx
CeNeS Pharmaceuticals
Centocor
Cephalon
Cerebral Vascular
Ceregene
Cerephex
Cerimon
Cervelo
Chase Pharmaceuticals
Checkpoint Surgical
Chestnut Medical
Chiesi Farmaceutici
Chiron
Chondrogene
Chronix Biomedical
Chugai
CIRTEC Medical
Clarus Medical
Clera
Cleveland Clinic
Cleveland Medical Devices
Clinical Data
CNS Response
CNS Vital Signs
CoAxia
Cochlear Ltd.
Codman
Cogmed
CogniFit
Cognition Pharmaceuticals
Cognitive Drug Research
Cognitive Pharma
Cognosci
CogState
CoLucid
CombinatoRx
CoMentis
Compumedics
Concentric Medical
Concert Pharmaceuticals
ConoGenetix
Corcept Therapeutics
Cordis
Cortech
Cortex
Covidien
CPS Innovations
CTI Molecular Imaging
Cubist
Curidium
Curis
CVRx
Cyberkinetics
CyberLearning
Cyberonics
Cynapsus
Cypress Bioscience
Cytos
Cytox

D

D-Pharm
Daiichi Sankyo
Dainippon
Dakim
DarPharma
Dart Neuroscience
Debiopharm
DeCODE Genetics
DiaGenic
Dianippon
DNATraits
Domain Therapeutics
Douglas Pharmaceuticals
Dov Pharmaceuticals
Durect
Dynogen

E

EBS Technologies
EEG Spectrum
Eisai
Ekos
Elan
Elbion
elbion
Elecelyx
Electrical Geodesics
ElectroCore
Elekta
Eli Lilly
Elixir
Ellipsis
ElMinda
Embera
Emisphere
EMKinetics
EndoGastric Solutions
Endogastric Solutions
Endo Pharmaceuticals
Enkam Pharmaceuticals
eNOS
Enpath
Ensemble Discovery
EnteroMedics
EnVivo Pharmaceuticals
Envoy Medical
Envoy Therapeutics
Eos Neuroscience
Epic Biosonics
EpiCept
Epix Pharmaceuticals
Ethicon
Euthymics Bioscience
Everest Biomedical
Evotec
ExonHit
EyeCyte
Eyetech

F

Fabre-Kramer
Faust
FineTech Medical
FoldRx
Fonar
Forest Labs
Fovea

G

g-Nostics
Galenea
Gamma Medica
Garnet BioTherapeutics
GE
Gedeon Richter
Gelesis
Genaera
Gene Express
GeneNews Limited
Genentech
Genesis Medical Imaging
GenPath Pharmaceuticals
GenVec
Genzyme
Geron
GI Dynamics
Gladstone Institute
GlaxoSmithKline
Glenmark
Greatbatch
Guilford Pharmaceuticals
GW Pharmaceuticals

H

H. Lundbeck
Hamilton Pharmaceuticals
Helicon Therapeutics
Heptares
High Q Foundation
Hitachi Medical
Hunter Fleming
Hydra Biosciences
Hypnion

I

i Research
Icagen
Icogenix
IIP-Technologies
Ikano Therapeutics
Imagine Neuro Solutions
Imagine Pharmaceuticals
ImaRx
Impax
ImThera Medical
Inflazyme
Ingenium
InnerCool
InSet Technologies
InSound
Inspire Medical
Integra
Integrated Sensing Systems
Intelect Medical
IntelGenx
Intelligent Medical Implants
International Stem Cell Corporation
Intra-Cellular
Intranasal Therapeutics
Intrapace
Invitrogen
InVivo
Ionix
Ipsen
iZumi Bio

J

Janssen
Janssen-Cilag
Javelin
Jazz Pharmaceuticals
Johns Hopkins Brain Science Institute
Johnson & Johnson
Jomed
Juvantia

K

Kadmus
Kai Pharmaceuticals
Kalypsys
Kappametrics
KeyNeurotek
KidsDx
Kinexis
King Pharmaceuticals
Kitalpha Med
Knopp
Kosei
Kowa
Krenitsky Pharmaceuticals
Kurve Technology
Kyowa

L

LA MONT Medical
Leptos
Lexicon
Lexicor Medical
Ligand
Limerick Neurosciences
Link Medicine
Luitpold
Lumos Labs

M

M's Science
M.J. Fox Foundation
Maas Biolab
Magstim
Mallinckrodt
MAP Pharmaceuticals
Marco Polo
Marinus
MDRNA
MED-EL
Meda
MedAvante
MedCool
MedGenesis
MediciNova
MedImpulse
Meditor
MediVance
Medivation
Medra
Medtrode
Medtronic
Meiji Seika Kaisha
Memory Pharmaceuticals
Merck
Merck Serono
Merlin
Merz
Metabolon
MetaCure
Metaphore Pharmaceuticals
Michael J. Fox Foundation
Micro Therapeutics
MicroTransponder
MicroVention
Micrus Endovascular
MindCare
MindFrame
Mind Research Network
Mindset
Mithridion
Mitsubishi Pharma
Mochida
Moeller Medical
Molecular Neuroimaging
MRC Systems
Myomo
Myriad

N

Nabi
NanoDel
NanoNerve
Nano Retina
Nanovector
Natus Medical
Naurex
Nautilus Neuro
Navigenics
NDI Medical
Neopraxis
Neostim
Ness
Neura
Neuralieve
Neural Signals
NeuralStem
Neuraltus
Neuralynx
Neuraxon
Neurelec
Neuren
Neurex
Neurim
Neurimmune Therapeutics
NeuroActive
Neurobiological Technologies
Neuro Biomed
NeuroBionics
NeuroBiotec
Neurocare
Neurochem
Neurocrine
Neurodan
NeuroDiscovery
NeuroDx Development
Neurodyne
Neurofit
NeuroFlo
NeuroFluidics
NeuroFocus
Neurogen
NeuroGeneration
Neurogenetics
NeuroGenomeX
NeurogesX
NeuroHealing
Neuro Hi-Tech Pharmaceuticals
Neuro Kinetics
Neurokos
NeuroLink Medical
NeuroLogic
NeuroLogica
Neurologics
Neurologix
Neurolutions
NeuroMark
Neuromed
NeuroMetrix
NeuroNascent
Neuronax
Neuronetics
Neuronetrix
NeuroNexus
NeuroNova
NeuroPace
NeuroPhysics
NeuroProfile
Neuroptix
Neuroscan
NeuroScience Pharmaceuticals
NeuroSearch
Neuros Medical
NeuroSolutions
NeuroSonix
NeuroSync
Neurotech SA
NeuroTherapeutics Pharma
NeuroTrax
Neurotune
NeuroVasx
NeuroVigil
NeuroVista
NeuroVive
Nevro
New River Pharmaceuticals
Newron
Nexstim
NFocus
Nicolet Biomedical
Nihon Kohden
Nocacea
Northstar Neuroscience
Noscira
Novadel
Novartis
NovaVision
Noven
NovoNordisk
Novosis
NPS Pharmaceuticals
NsGene
Nuon Therapeutics
NuPathe
Nymox

O

Obecure
Odyssey
Omeros
Omneuron
Ono Pharmaceuticals
Opexa
Ophthotech
OPKO
Optherion
Opthotech
Optimal Medicine
Optima Neuroscience
Optobionics
OptumHealth
Ora Bio
Orasi Medical
Oraya Therapeutics
Orexeo
Orexigen
Organon
Orphan Medical
Ortho-McNeil
Oryx Pharmaceuticals
OSI Pharmaceuticals
Othera
OtoKinetics
Otonomy
Otsuka
Ovation Pharmaceuticals
Oxford Biomedica
Oxford Instruments
Oxigene

P

PainCeptor
Pain Therapeutics
Paion
Palatin
Palyon
Panacea
Pathogenics
Pentech
Penwest
Peptimmune
Pfizer
Pfizer's
Pharmacia
PharmaNess
PharmaNeuroBoost
PharmaPass
PharmatrophiX
Pharmaxon
Pharmos
Pharnext
Phase Discovery
Pherin
Philips
PhotoThera
Physiometrix
PhysioSonics
Phytopharm
Picker
Plexon
Posit
Positron Corporation
Pozen
Prana
Prestwick Pharmaceuticals
Pritzker Neuropsychiatric Disorders Research Consortium
Probiodrug
ProEthic
Progenics
Proneuron
Prosense
Prospex Medical
Protalix
Proteotech
Provista Diagnostics
Proximagen Neuroscience
pSividia
Psyadon
Psychogenics
Psylin
Psynova
Purdue

Q

QR Pharma
QRxPharma
Q Therapeutics
Quark Pharmaceuticals
Questcor
Quickcool

R

Radiant Medical
Radionic's
Ranbaxy
Raptor
Reata Pharmaceuticals
Reckitt Benckiser
RedPlane
Regenecor
Regeneron
Relievant Medsystems
reMYND
ReNeuron
Renovis
Repligen
Retina Implant
RetinaPharma
Reverse Medical
Rexahn
Rhenovia
RhinoCyte
Rhythm Pharma
RIKEN
Rinat
Rivanna
Roche
RoxRo
Rules-Based Medicine

S

Sabine Neurotechnology
Sanofi-Aventis
Santhera
SantoSolve
Satiety
Satori
Satoris
Schering-Plough
Schwarz
Sciele
Scientific Brain Training
Scientific Learning
Scion Pharmaceuticals
Second Sight
Seimens
Senexis
SeneXta
Senomyx
Sensory Medical
Sepracor
Servier
SetPoint Medical
Shimadzu Medical Systems
Shionogi
Shire
Siemens
Siena Biotech
Sierra Neuropharmaceuticals
Sigmedics
Signum Biosciences
Silere Medical
Simprota
Sirion
SIRNA
SK Bio-Pharmaceuticals
SleepMed
Solace Pharmaceuticals
Solstice
Solvay
Somanetics
Somaxon
Somerset Pharmaceuticals
Somnus
Sonexa
Sonova
Sosei
Sound Pharmaceuticals
Spencer Technologies
Spherics
Spinal Cord Therapeutics
Spinal Modulation
SPR Therapeutics
St. Croix Medical
St. Jude Medical
Stem Cell Innovations
Stem Cells Inc.
StemCells California
Stem Cell Sciences
StemCell Technologies
Stem Cell Therapeutics
Stemedica
Stereotaxis
St Jude Medical
Stryker
Summit
Supernus
Suven
Sygnis
Synapse Biomedical
Synaptic Pharmaceutical
Synergia Pharma
Syngenta
Syngis
Synosia
Syntaxin
Syntropharma

T

Taisho
Takeda
Tanabe
Targacept
Targegen
TauRx Therapeutics
TauTaTis
TeachTown
TeraRecon
Terumo
Teva
Texcel Medical
Theracos
Theradigm
TheraGenetics
TheraNova
TheraQuest
Theravance
Thiakis
Thuris
Tikvah
Titan
toBBB
TorreyPines
Toshiba
Touch Bionics
Transcept Pharma
Transcription Diagnostics
Transition Therapeutics
TransMolecular
TransOral
TransTech
Tranzyme
Trevena
Treventis
Trophos
Tucker-Davis

U

UCB
Unique Logic and Technology
Upsher-Smith
US Worldmeds

V

Valeant
Validus
Vanda
Vantage Mobile Services
Varian
Vastox
Vela Pharmaceuticals
Velocimed
Vernalis
Vertex
Victhom Human Bionics
Victory
VisionCare Ophthalmic
Vitae
Vivity Labs
Vivus
Voyager Pharmaceutical

W

Wicab
Wild Divine
Wyeth

X

Xanodyne
Xcel Pharmaceuticals
Xenome
Xenon
XenoPort
Xenova
Xention
Xigen
Xsira
Xytis
Y

Yaupon

Z

Zenobia Therapeutics
Zogenix
Zoll Medical
Zynex

Customers who bought this item also bought

• Pain Management Devices - Global Strategic Business Report
• World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast
• IV Fluid Transfer Devices Products, Players, Markets and Opportunities
• RNA Interference (RNAi) - Global Strategic Business Report
• Guide to U.S. Specialty Pharmaceutical Market: Companies, Products and Market Data
• Nuclear Medicine - Global Strategic Business Report
• Pediatric Drugs and Vaccines - Global Business Strategic Report
• Global Biopharmaceutical Market Report & Forecast (2012-2017)
• Ion Channel Modulators - Global Strategic Business Report
• CNS Therapeutics - Global Strategic Business Report